BackCreative Medical Technology Holdings Overview

Creative Medical Technology Holdings Other Assets

Track Creative Medical Technology Holdings's other assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

Creative Medical Technology Holdings Other Assets History

Loading

Creative Medical Technology Holdings vs. peers: Other Assets Comparison

Loading

Creative Medical Technology Holdings Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Creative Medical Technology Holdings (CELZ) FAQ

Creative Medical Technology Holdings (CELZ) currently reports a other assets of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Creative Medical Technology Holdings's other assets history and peer comparisons.

Creative Medical Technology Holdings's other assets changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Creative Medical Technology Holdings reported $0 in other assets as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Creative Medical Technology Holdings, and consider following CELZ for alerts when major investors trade the stock.